Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NovaBay Pharmaceuticals I...

    AMEX: NBY · Real-Time Price · USD
    0.59
    -0.01 (-2.45%)
    At close: Aug 15, 2025, 11:26 AM

    NovaBay Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.78M 10.46M 14.4M 8.42M
    Cost of Revenue
    		 3.3M 4.37M 6.62M 2.78M
    Gross Profit
    		 6.48M 6.08M 7.78M 5.64M
    Operating Income
    		 -5.84M -5M -7.68M -8.86M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -7.21M -9.64M -10.61M -5.82M
    Net Income
    		 -7.22M -9.64M -16.27M -6.56M
    Selling & General & Admin
    		 11.41M 12.83M 15.29M 14.46M
    Research & Development
    		 42K 68K 174K 44K
    Other Expenses
    		 865K n/a n/a n/a
    Operating Expenses
    		 12.32M 12.9M 15.46M 14.51M
    Interest Expense
    		 904K 1.69M n/a n/a
    Selling & Marketing Expenses
    		 4.03M 6.5M 7.8M 7.22M
    Cost & Expenses
    		 15.62M 19.73M 22.08M 17.28M
    Income Tax Expense
    		 n/a n/a -3.81M -4.62M
    Shares Outstanding (Basic)
    		 3.4M 120K 30K 31.64K
    Shares Outstanding (Diluted)
    		 3.4M 120K 46K 35.63K
    EPS (Basic)
    		 -2.53 -139.14 -353.59 -184.09
    EPS (Diluted)
    		 -2.53 -138.65 -353.59 -184.09
    EBITDA
    		 -5.92M -4.8M -7.2M -8.74M
    EBIT
    		 -6.31M -5M -7.68M -8.86M
    Depreciation & Amortization
    		 381K 203K 483K 119K

    Add to Watchlist